{"id":31812,"date":"2025-09-18T09:25:34","date_gmt":"2025-09-18T07:25:34","guid":{"rendered":"https:\/\/www.eurotranspharma.com\/vaccine-distribution-europe\/"},"modified":"2025-09-18T10:03:01","modified_gmt":"2025-09-18T08:03:01","slug":"distribuce-vakcin-evropa","status":"publish","type":"post","link":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/","title":{"rendered":"Distribuce vakc\u00edn v Evrop\u011b: Osv\u011bd\u010den\u00e9 modely pro ka\u017ed\u00fd trh"},"content":{"rendered":"[vc_row type=“in_container“ full_screen_row_position=“middle“ column_margin=“default“ column_direction=“default“ column_direction_tablet=“default“ column_direction_phone=“default“ scene_position=“center“ text_color=“dark“ text_align=“left“ row_border_radius=“none“ row_border_radius_applies=“bg“ overflow=“visible“ overlay_strength=“0.3″ gradient_direction=“left_to_right“ shape_divider_position=“bottom“ bg_image_animation=“none“][vc_column column_padding=“no-extra-padding“ column_padding_tablet=“inherit“ column_padding_phone=“inherit“ column_padding_position=“all“ column_element_direction_desktop=“default“ column_element_spacing=“default“ desktop_text_alignment=“default“ tablet_text_alignment=“default“ phone_text_alignment=“default“ background_color_opacity=“1″ background_hover_color_opacity=“1″ column_backdrop_filter=“none“ column_shadow=“none“ column_border_radius=“none“ column_link_target=“_self“ column_position=“default“ gradient_direction=“left_to_right“ overlay_strength=“0.3″ width=“1\/1″ tablet_width_inherit=“default“ animation_type=“default“ bg_image_animation=“none“ border_type=“simple“ column_border_width=“none“ column_border_style=“solid“][vc_column_text css=““ text_direction=“default“]Vakc\u00edny chr\u00e1n\u00ed lidi pouze tehdy, jsou-li dod\u00e1ny v\u010das, na spr\u00e1vn\u00e9 m\u00edsto a za spr\u00e1vn\u00fdch podm\u00ednek. V cel\u00e9 Evrop\u011b je distribuce ovliv\u0148ov\u00e1na n\u00e1rodn\u00edmi zdravotn\u00edmi syst\u00e9my, m\u00edstn\u00edmi p\u0159edpisy a n\u011bkdy i pozornost\u00ed ve\u0159ejnosti.<\/p>\n

Eurotranspharma spravuje \u0161irok\u00e9 portfolio vakc\u00edn, od n\u00e1rodn\u00edch imuniza\u010dn\u00edch program\u016f po sez\u00f3nn\u00ed kampan\u011b, jako jsou vakc\u00edny proti ch\u0159ipce, pta\u010d\u00ed ch\u0159ipce a Covidu. Ka\u017ed\u00fd rok p\u0159edstavuj\u00ed tyto kampan\u011b slo\u017eitou logistickou v\u00fdzvu, kterou na\u0161e t\u00fdmy \u0159e\u0161\u00ed s odhodl\u00e1n\u00edm, agilitou a flexibilitou. V pr\u016fb\u011bhu \u010dasu tyto siln\u00e9 str\u00e1nky vybudovaly celoevropskou s\u00ed\u0165, kter\u00e1 kombinuje m\u00edstn\u00ed odborn\u00e9 znalosti s bezkonkuren\u010dn\u00edm pokryt\u00edm a konzistentn\u00edmi vysok\u00fdmi standardy kvality.<\/p>\n

D\u00edky jedin\u00e9mu partnerovi se v\u00fdrobci a logisti\u010dt\u00ed dodavatel\u00e9 mohou spolehnout na spole\u010dnost Eurotranspharma, kter\u00e1 dod\u00e1v\u00e1 vakc\u00edny po cel\u00e9 Evrop\u011b prost\u0159ednictv\u00edm \u0161k\u00e1lovateln\u00fdch, spolehliv\u00fdch p\u0159epravn\u00edch \u0159e\u0161en\u00ed, pln\u011b v souladu s pokyny GDP.<\/p>\n

Jedine\u010dn\u00e1 s\u00ed\u0165 dod\u00e1vaj\u00edc\u00ed na m\u00edstn\u00ed trhy\u00a0 <\/strong><\/p>\n

Jakmile jsou vakc\u00edny uvoln\u011bny od v\u00fdrobce, laborato\u0159e nebo distributora, p\u0159eb\u00edr\u00e1 je Eurotranspharma a dod\u00e1v\u00e1 je velkoobchodn\u00edk\u016fm, l\u00e9k\u00e1rn\u00e1m, nemocnic\u00edm, o\u010dkovac\u00edm centr\u016fm a dal\u0161\u00edm zdravotnick\u00fdm pracovn\u00edk\u016fm po cel\u00e9 Evrop\u011b. Ji\u017e v\u00edce ne\u017e deset let zaji\u0161\u0165uje na\u0161e s\u00ed\u0165 tuto kritickou posledn\u00ed f\u00e1zi s p\u0159esnost\u00ed a p\u0159izp\u016fsobuje se jak distribu\u010dn\u00edm strategi\u00edm v\u00fdrobc\u016f, tak po\u017eadavk\u016fm m\u00edstn\u00edch zdravotnick\u00fdch syst\u00e9m\u016f.<\/p>\n

Ka\u017ed\u00fd trh vy\u017eaduje jin\u00fd model fungov\u00e1n\u00ed. Ve Francii jsou vakc\u00edny dod\u00e1v\u00e1ny p\u0159\u00edmo od v\u00fdrobc\u016f k p\u0159\u00edjemc\u016fm, s vyhrazen\u00fdm pl\u00e1nov\u00e1n\u00edm, kter\u00e9 udr\u017euje toky p\u0159edv\u00eddateln\u00e9 b\u011bhem kampan\u00ed. V Beneluxu se kampan\u011b rozkl\u00e1daj\u00ed na n\u011bkolik m\u011bs\u00edc\u016f, co\u017e vy\u017eaduje trval\u00e9 zdroje k zaji\u0161t\u011bn\u00ed v\u00fdkonu b\u011bhem dlouh\u00e9ho vrcholu. Ve \u0160pan\u011blsku poskytuje agiln\u00ed spolupr\u00e1ce 3PL flexibilitu pro dosa\u017een\u00ed m\u011bstsk\u00fdch center i odlehl\u00fdch region\u016f. V N\u011bmecku proch\u00e1zej\u00ed z\u00e1silky p\u0159es p\u0159edvelkoobchodn\u00edky<\/span> distributory a p\u0159ed uvoln\u011bn\u00edm vy\u017eaduj\u00ed schv\u00e1len\u00ed \u00fa\u0159ady. V\u0161e koordinujeme, aby byly l\u00e9k\u00e1rny a l\u00e9ka\u0159i z\u00e1sobov\u00e1ni v\u010das.<\/p>\n

\u201eV N\u011bmecku obsluhujeme 18 000 l\u00e9k\u00e1ren a 120 000 l\u00e9ka\u0159\u016f v p\u0159\u00edsn\u00fdch term\u00ednech. Ka\u017ed\u00e1 z\u00e1silka mus\u00ed proj\u00edt p\u0159es p\u0159edvelkoobchodn\u00edky a z\u00edskat povolen\u00ed od \u00fa\u0159ad\u016f, proto je pro dodr\u017eov\u00e1n\u00ed term\u00edn\u016f dod\u00e1vek nezbytn\u00e1 \u00fazk\u00e1 spolupr\u00e1ce s m\u00edstn\u00edmi \u00fa\u0159ady,\u201c <\/em>poznamen\u00e1v\u00e1 Uwe Brosius, provozn\u00ed \u0159editel spole\u010dnosti Eurotranspharma Germany.<\/strong><\/p>\n

P\u0159\u00edprava se snoub\u00ed s agilitou<\/strong><\/p>\n

P\u0159\u00edprava na o\u010dkovac\u00ed kampan\u011b ve spole\u010dnosti Eurotranspharma za\u010d\u00edn\u00e1 n\u011bkolik m\u011bs\u00edc\u016f p\u0159edem. Od \u010dervna se koordinuj\u00ed vozov\u00e9 parky, person\u00e1l a \u0161kolen\u00ed, aby byly operace p\u0159ipraveny na distribuci v z\u00e1\u0159\u00ed nebo \u0159\u00edjnu. Pokud objemy vakc\u00edn odpov\u00eddaj\u00ed na\u0161im b\u011b\u017en\u00fdm logistick\u00fdm sch\u00e9mat\u016fm, jsou hladce integrov\u00e1ny. Pokud logistick\u00e9 kan\u00e1ly vy\u017eaduj\u00ed n\u011bco jin\u00e9ho, nap\u0159\u00edklad specializovan\u00e9 dod\u00e1vky pouze do o\u010dkovac\u00edch center, Eurotranspharma navrhne \u0159e\u0161en\u00ed na m\u00edru s dedikovan\u00fdmi \u0159e\u0161en\u00edmi. V obou p\u0159\u00edpadech jsou zdroje p\u0159izp\u016fsobeny tak, aby odpov\u00eddaly zv\u00fd\u0161en\u00fdm objem\u016fm a okolnostem.<\/p>\n

P\u0159\u00edprava vytv\u00e1\u0159\u00ed odolnost, ale agilita zaji\u0161\u0165uje v\u00fdsledky. \u00darove\u0148 epidemie, z\u00e1jem o kampa\u0148 nebo zm\u011bny v p\u0159edpisech mohou popt\u00e1vku zm\u011bnit p\u0159es noc. Preventivn\u00ed kampan\u011b, kter\u00e9 dos\u00e1hnou siln\u00e9 odezvy ve\u0159ejnosti, mohou tak\u00e9 popt\u00e1vku urychlit. V N\u011bmecku p\u0159edch\u00e1z\u00ed p\u0159edb\u011b\u017en\u00e1 koordinace s \u00fa\u0159ady zpo\u017ed\u011bn\u00edm p\u0159i odbaven\u00ed. Ve \u0160pan\u011blsku b\u011bhem COVID-19 klesly objemy vakc\u00edn proti ch\u0159ipce, zat\u00edmco popt\u00e1vka po flexibiln\u00ed logistice se zdvojn\u00e1sobila, co\u017e vy\u017eadovalo rychl\u00e9 p\u0159erozd\u011blen\u00ed zdroj\u016f.<\/p>\n

\u201eB\u011bhem ch\u0159ipkov\u00e9 sez\u00f3ny jsme roz\u0161\u00ed\u0159ili na\u0161i flotilu ve \u0160pan\u011blsku, abychom zajistili pokryt\u00ed cel\u00e9ho \u00fazem\u00ed. Tato flexibilita n\u00e1m umo\u017enila obsluhovat o\u010dkovac\u00ed centra po cel\u00e9 zemi, v\u010detn\u011b odlehl\u00fdch region\u016f.\u201c \u2013 <\/em>Felix Ramos, provozn\u00ed \u0159editel Eurotranspharma Spain.<\/strong><\/p>\n

Ve\u0159ejn\u00e1 komunikace m\u016f\u017ee tak\u00e9 zes\u00edlit popt\u00e1vku. Eurotranspharma se na tuto dynamiku p\u0159ipravuje flexibiln\u00edm provozem, p\u0159izp\u016fsoben\u00edm zdroj\u016f a \u00fapravou p\u0159epravn\u00edch pl\u00e1n\u016f, aby kampan\u011b z\u016fstaly i pod tlakem na spr\u00e1vn\u00e9 cest\u011b.<\/p>\n

V cel\u00e9 Evrop\u011b je to pr\u00e1v\u011b rovnov\u00e1ha mezi v\u010dasnou p\u0159\u00edpravou a opera\u010dn\u00ed flexibilitou, kter\u00e1 \u010din\u00ed Eurotranspharma d\u016fv\u011bryhodn\u00fdm partnerem v distribuci vakc\u00edn.<\/p>\n

Chladic\u00ed \u0159et\u011bzec bez kompromis\u016f<\/strong><\/p>\n

\u00da\u010dinnost vakc\u00edny z\u00e1vis\u00ed na udr\u017een\u00ed teploty v rozmez\u00ed 2 \u00b0C a\u017e 8 \u00b0C. Eurotranspharma chr\u00e1n\u00ed chladic\u00ed \u0159et\u011bzec pomoc\u00ed vozidel s dvojitou komorou vybaven\u00fdch technologi\u00ed IoT, monitorov\u00e1n\u00edm v re\u00e1ln\u00e9m \u010dase a povinnou certifikac\u00ed \u0159idi\u010d\u016f. Automatizovan\u00e1 upozorn\u011bn\u00ed sni\u017euj\u00ed teplotn\u00ed odchylky ve srovn\u00e1n\u00ed s manu\u00e1ln\u00edmi kontrolami, co\u017e zvy\u0161uje spolehlivost kampan\u00ed.<\/p>\n

Kvalita v j\u00e1dru<\/span> je z\u00e1kladem<\/strong><\/p>\n

Za ka\u017edou dod\u00e1vkou vakc\u00edn stoj\u00ed p\u0159\u00edsn\u00fd syst\u00e9m kvality. Procesy spole\u010dnosti Eurotranspharma jsou pln\u011b v souladu s pokyny GDP a jsou pos\u00edleny pr\u016fb\u011b\u017en\u00fdmi audity, monitorov\u00e1n\u00edm a \u0161kolen\u00edm zam\u011bstnanc\u016f. T\u00edm je zaji\u0161t\u011bno, \u017ee dodr\u017eov\u00e1n\u00ed p\u0159edpis\u016f nen\u00ed a\u017e druho\u0159adou z\u00e1le\u017eitost\u00ed, ale ned\u00edlnou sou\u010d\u00e1st\u00ed ka\u017edodenn\u00edho provozu.<\/p>\n

\u201eKvalita nen\u00ed jen slib, je zakotvena v ka\u017ed\u00e9 f\u00e1zi na\u0161eho distribu\u010dn\u00edho procesu. Od \u0161kolen\u00ed p\u0159es monitorov\u00e1n\u00ed a\u017e po pod\u00e1v\u00e1n\u00ed zpr\u00e1v pracuj\u00ed na\u0161e t\u00fdmy ka\u017ed\u00fd den podle standard\u016f GDP, aby partne\u0159i ve zdravotnictv\u00ed mohli m\u00edt plnou d\u016fv\u011bru v o\u010dkovac\u00ed l\u00e1tky, kter\u00e9 dod\u00e1v\u00e1me.\u201c \u2013 <\/em>Marc Venot, \u0159editel pro kvalitu ve spole\u010dnosti Eurotranspharma<\/strong><\/p>\n

Technologie a spolupr\u00e1ce<\/strong><\/p>\n

Technologie a spolupr\u00e1ce jdou ruku v ruce v logistice vakc\u00edn. Na\u0161e n\u00e1stroje pro business intelligence poskytuj\u00ed p\u0159ehled v re\u00e1ln\u00e9m \u010dase, ozna\u010duj\u00ed z\u00e1silky vakc\u00edn pro prioritn\u00ed zpracov\u00e1n\u00ed a generuj\u00ed zpr\u00e1vy p\u0159ipraven\u00e9 k auditu. Denn\u00ed aktualizace o dodr\u017eov\u00e1n\u00ed GDP jsou sd\u00edleny se zainteresovan\u00fdmi stranami, co\u017e poskytuje okam\u017eit\u00fd d\u016fkaz, \u017ee ka\u017ed\u00e1 z\u00e1silka z\u016fst\u00e1v\u00e1 v r\u00e1mci stanoven\u00e9ho rozsahu.<\/p>\n

Stejn\u011b d\u016fle\u017eit\u00e1 je i spolupr\u00e1ce. \u00dazce spolupracujeme s v\u00fdrobci, p\u0159edvelkoobchodn\u00edky, partnery 3PL a zdravotnick\u00fdmi \u00fa\u0159ady. Ve Francii se b\u011bhem kampan\u00ed proti ch\u0159ipce konaj\u00ed t\u00fddenn\u00ed sch\u016fzky, na kter\u00fdch se v\u0161echny t\u00fdmy domluv\u00ed, aby se probl\u00e9my vy\u0159e\u0161ily d\u0159\u00edve, ne\u017e ovlivn\u00ed dod\u00e1vky. \u201eVe Francii jsme b\u011bhem n\u011bkolika dn\u00ed doru\u010dili 35 000 z\u00e1silek vakc\u00edn p\u0159i pln\u00e9m dodr\u017een\u00ed p\u0159edpis\u016f GDP. D\u00edky report\u016fm v re\u00e1ln\u00e9m \u010dase pro v\u00fdrobce a zdravotnick\u00e9 \u00fa\u0159ady m\u011bli b\u011bhem kampan\u011b \u00fapln\u00fd p\u0159ehled.\u201c <\/em>\u2013<\/strong> Franck Morodei, provozn\u00ed \u0159editel Eurotranspharma France.<\/strong><\/p>\n

Technologie a spolupr\u00e1ce spole\u010dn\u011b zaji\u0161\u0165uj\u00ed, \u017ee Eurotranspharma poskytuje nejen bezpe\u010dnou p\u0159epravu, ale tak\u00e9 transparentnost a d\u016fv\u011bru, kter\u00e9 o\u010dkovac\u00ed kampan\u011b vy\u017eaduj\u00ed.<\/p>\n

D\u016fv\u011bryhodn\u00fd partner v logistice vakc\u00edn<\/strong><\/p>\n

Distribuce vakc\u00edn nen\u00ed nikdy rutinn\u00ed z\u00e1le\u017eitost\u00ed. Vy\u017eaduje v\u010dasnou p\u0159\u00edpravu, p\u0159\u00edsn\u00e9 dodr\u017eov\u00e1n\u00ed p\u0159edpis\u016f a schopnost pru\u017en\u011b se p\u0159izp\u016fsobit zm\u011bn\u00e1m okolnost\u00ed.<\/p>\n

\u201eV Beneluxu je distribuce decentralizovan\u00e1. \u010casto vytv\u00e1\u0159\u00edme p\u0159epravn\u00ed pl\u00e1ny na m\u00edru a v dob\u011b vrcholu kampan\u011b zvy\u0161ujeme zdroje a\u017e o 80 procent, abychom splnili m\u00edstn\u00ed po\u017eadavky,\u201c <\/em>zd\u016fraz\u0148uje Eli Smeding, provozn\u00ed mana\u017eer spole\u010dnosti Eurotranspharma Benelux ( ).<\/strong><\/p>\n

Eurotranspharma kombinuje v\u00edce ne\u017e deset let zku\u0161enost\u00ed s vakc\u00ednami s celoevropskou s\u00edt\u00ed, osv\u011bd\u010denou spolehlivost\u00ed chladic\u00edho \u0159et\u011bzce a provozn\u00ed flexibilitou. Na\u0161e v\u00fdsledky hovo\u0159\u00ed samy za sebe \u2013 obsluhujeme v\u00edce ne\u017e 100 000 l\u00e9k\u00e1ren a p\u0159ibli\u017en\u011b 8 000 nemocnic <\/strong>po cel\u00e9 Evrop\u011b.<\/p>\n

Zdravotnick\u00fdm org\u00e1n\u016fm, v\u00fdrobc\u016fm a partner\u016fm dod\u00e1v\u00e1me vakc\u00edny bezpe\u010dn\u011b, v\u010das a s odpov\u00eddaj\u00edc\u00ed m\u00edrou transparentnosti a souladu s p\u0159edpisy. Eurotranspharma se zav\u00e1zala chr\u00e1nit ka\u017edou d\u00e1vku a ka\u017ed\u00e9ho pacienta, v ka\u017ed\u00e9m ro\u010dn\u00edm obdob\u00ed.[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=“full_width_background“ full_screen_row_position=“middle“ column_margin=“default“ column_direction=“default“ column_direction_tablet=“default“ column_direction_phone=“default“ bg_color=“#FFFFFF“ scene_position=“center“ top_padding=“20″ bottom_padding=“20″ left_padding_desktop=“0″ top_margin=“1%“ bottom_margin=“3%“ text_color=“dark“ text_align=“left“ row_border_radius=“none“ row_border_radius_applies=“bg“ overflow=“visible“ overlay_strength=“0.3″ gradient_direction=“left_to_right“ shape_divider_position=“bottom“ bg_image_animation=“none“ shape_type=““ gradient_type=“default“][vc_column column_padding=“no-extra-padding“ column_padding_tablet=“inherit“ column_padding_phone=“inherit“ column_padding_position=“all“ column_element_direction_desktop=“default“ column_element_spacing=“default“ desktop_text_alignment=“default“ tablet_text_alignment=“default“ phone_text_alignment=“default“ background_color_opacity=“1″ background_hover_color_opacity=“1″ column_backdrop_filter=“none“ column_shadow=“none“ column_border_radius=“none“ column_link_target=“_self“ column_position=“default“ gradient_direction=“left_to_right“ overlay_strength=“0.3″ width=“1\/6″ tablet_width_inherit=“default“ animation_type=“default“ bg_image_animation=“none“ border_type=“simple“ column_border_width=“none“ column_border_style=“solid“][\/vc_column][vc_column column_padding=“no-extra-padding“ column_padding_tablet=“inherit“ column_padding_phone=“inherit“ column_padding_position=“all“ column_element_direction_desktop=“default“ column_element_spacing=“default“ desktop_text_alignment=“default“ tablet_text_alignment=“default“ phone_text_alignment=“default“ background_color_opacity=“1″ background_hover_color_opacity=“1″ column_backdrop_filter=“none“ column_shadow=“none“ column_border_radius=“none“ column_link_target=“_self“ column_position=“default“ gradient_direction=“left_to_right“ overlay_strength=“0.3″ width=“2\/3″ tablet_width_inherit=“default“ animation_type=“default“ bg_image_animation=“none“ border_type=“simple“ column_border_width=“none“ column_border_style=“solid“][nectar_btn size=“large“ open_new_tab=“true“ button_style=“regular“ button_color_2=“Accent-Color“ icon_family=“none“ text=“Napl\u00e1nujte si distribuci vakc\u00edn je\u0161t\u011b dnes \u2013 Kontaktujte n\u00e1s“ url=“https:\/\/www.eurotranspharma.com\/cs\/kontakt\/“ css_animation=“bounceInLeft“][\/vc_column][vc_column column_padding=“no-extra-padding“ column_padding_tablet=“inherit“ column_padding_phone=“inherit“ column_padding_position=“all“ column_element_direction_desktop=“default“ column_element_spacing=“default“ desktop_text_alignment=“default“ tablet_text_alignment=“default“ phone_text_alignment=“default“ background_color_opacity=“1″ background_hover_color_opacity=“1″ column_backdrop_filter=“none“ column_shadow=“none“ column_border_radius=“none“ column_link_target=“_self“ column_position=“default“ gradient_direction=“left_to_right“ overlay_strength=“0.3″ width=“1\/6″ tablet_width_inherit=“default“ animation_type=“default“ bg_image_animation=“none“ border_type=“simple“ column_border_width=“none“ column_border_style=“solid“][\/vc_column][\/vc_row][vc_row type=“full_width_background“ full_screen_row_position=“middle“ column_margin=“default“ column_direction=“default“ column_direction_tablet=“default“ column_direction_phone=“default“ bg_color=“#E8E8E8″ scene_position=“center“ text_color=“dark“ text_align=“left“ row_border_radius=“none“ row_border_radius_applies=“bg“ overflow=“visible“ overlay_strength=“0.3″ gradient_direction=“left_to_right“ shape_divider_position=“bottom“ bg_image_animation=“none“ gradient_type=“default“ shape_type=““][vc_column column_padding=“no-extra-padding“ column_padding_tablet=“inherit“ column_padding_phone=“inherit“ column_padding_position=“all“ column_element_direction_desktop=“default“ column_element_spacing=“default“ desktop_text_alignment=“default“ tablet_text_alignment=“default“ phone_text_alignment=“default“ background_color_opacity=“1″ background_hover_color_opacity=“1″ column_backdrop_filter=“none“ column_shadow=“none“ column_border_radius=“none“ column_link_target=“_self“ column_position=“default“ gradient_direction=“left_to_right“ overlay_strength=“0.3″ width=“1\/1″ tablet_width_inherit=“default“ animation_type=“default“ bg_image_animation=“none“ border_type=“simple“ column_border_width=“none“ column_border_style=“solid“][vc_column_text css_animation=“none“ css=““ max_width=“800″ text_direction=“default“]\n

Novinky ze s\u00edt\u011b<\/h3>\n[\/vc_column_text][recent_posts style=“default“ columns=“3″ category=“all“ order=“DESC“ orderby=“date“ blog_remove_post_author=“true“ posts_per_page=“3″][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"

[vc_row type=“in_container“ full_screen_row_position=“middle“ column_margin=“default“ column_direction=“default“ column_direction_tablet=“default“ column_direction_phone=“default“ scene_position=“center“ text_color=“dark“ text_align=“left“ row_border_radius=“none“ row_border_radius_applies=“bg“ overflow=“visible“ overlay_strength=“0.3″ gradient_direction=“left_to_right“ shape_divider_position=“bottom“ bg_image_animation=“none“][vc_column column_padding=“no-extra-padding“ column_padding_tablet=“inherit“ column_padding_phone=“inherit“ column_padding_position=“all“ column_element_direction_desktop=“default“ column_element_spacing=“default“ desktop_text_alignment=“default“ tablet_text_alignment=“default“ phone_text_alignment=“default“ background_color_opacity=“1″ background_hover_color_opacity=“1″ column_backdrop_filter=“none“ column_shadow=“none“…<\/p>\n","protected":false},"author":3,"featured_media":31780,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58,95,60],"tags":[],"class_list":["post-31812","post","type-post","status-publish","format-standard","has-post-thumbnail","category-eurotranspharma-cs","category-healthcare-transport-cs","category-network-cs"],"yoast_head":"\nDistribuce vakc\u00edn v Evrop\u011b | Eurotranspharma<\/title>\n<meta name=\"description\" content=\"Eurotranspharma zaji\u0161\u0165uje GDP distribuci vakc\u00edn v cel\u00e9 Evrop\u011b s kontrolou chladic\u00edho \u0159et\u011bzce v re\u00e1ln\u00e9m \u010dase a lok\u00e1ln\u00edmi \u0159e\u0161en\u00edmi\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/\" \/>\n<meta property=\"og:locale\" content=\"cs_CZ\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Distribuce vakc\u00edn v Evrop\u011b | Eurotranspharma\" \/>\n<meta property=\"og:description\" content=\"Eurotranspharma zaji\u0161\u0165uje GDP distribuci vakc\u00edn v cel\u00e9 Evrop\u011b s kontrolou chladic\u00edho \u0159et\u011bzce v re\u00e1ln\u00e9m \u010dase a lok\u00e1ln\u00edmi \u0159e\u0161en\u00edmi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/\" \/>\n<meta property=\"og:site_name\" content=\"EUROTRANSPHARMA\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-18T07:25:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-18T08:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2025\/09\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1851\" \/>\n\t<meta property=\"og:image:height\" content=\"913\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Olha Hlias\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napsal(a)\" \/>\n\t<meta name=\"twitter:data1\" content=\"Olha Hlias\" \/>\n\t<meta name=\"twitter:label2\" content=\"Odhadovan\u00e1 doba \u010dten\u00ed\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/\"},\"author\":{\"name\":\"Olha Hlias\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/#\\\/schema\\\/person\\\/c752465ad6b1ea4d80bb1d6cf53f6fea\"},\"headline\":\"Distribuce vakc\u00edn v Evrop\u011b: Osv\u011bd\u010den\u00e9 modely pro ka\u017ed\u00fd trh\",\"datePublished\":\"2025-09-18T07:25:34+00:00\",\"dateModified\":\"2025-09-18T08:03:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/\"},\"wordCount\":2226,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg\",\"articleSection\":[\"Eurotranspharma\",\"Healthcare transport\",\"Network\"],\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/\",\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/\",\"name\":\"Distribuce vakc\u00edn v Evrop\u011b | Eurotranspharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg\",\"datePublished\":\"2025-09-18T07:25:34+00:00\",\"dateModified\":\"2025-09-18T08:03:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/#\\\/schema\\\/person\\\/c752465ad6b1ea4d80bb1d6cf53f6fea\"},\"description\":\"Eurotranspharma zaji\u0161\u0165uje GDP distribuci vakc\u00edn v cel\u00e9 Evrop\u011b s kontrolou chladic\u00edho \u0159et\u011bzce v re\u00e1ln\u00e9m \u010dase a lok\u00e1ln\u00edmi \u0159e\u0161en\u00edmi\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#breadcrumb\"},\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg\",\"contentUrl\":\"https:\\\/\\\/www.eurotranspharma.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg\",\"width\":1851,\"height\":913},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/distribuce-vakcin-evropa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Distribuce vakc\u00edn v Evrop\u011b: Osv\u011bd\u010den\u00e9 modely pro ka\u017ed\u00fd trh\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/#website\",\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/\",\"name\":\"EUROTRANSPHARMA\",\"description\":\"Healthcare Distribution Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"cs\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/#\\\/schema\\\/person\\\/c752465ad6b1ea4d80bb1d6cf53f6fea\",\"name\":\"Olha Hlias\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g\",\"caption\":\"Olha Hlias\"},\"url\":\"https:\\\/\\\/www.eurotranspharma.com\\\/cs\\\/author\\\/295d7e7afdf875edf6f11dba7011e287\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Distribuce vakc\u00edn v Evrop\u011b | Eurotranspharma","description":"Eurotranspharma zaji\u0161\u0165uje GDP distribuci vakc\u00edn v cel\u00e9 Evrop\u011b s kontrolou chladic\u00edho \u0159et\u011bzce v re\u00e1ln\u00e9m \u010dase a lok\u00e1ln\u00edmi \u0159e\u0161en\u00edmi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/","og_locale":"cs_CZ","og_type":"article","og_title":"Distribuce vakc\u00edn v Evrop\u011b | Eurotranspharma","og_description":"Eurotranspharma zaji\u0161\u0165uje GDP distribuci vakc\u00edn v cel\u00e9 Evrop\u011b s kontrolou chladic\u00edho \u0159et\u011bzce v re\u00e1ln\u00e9m \u010dase a lok\u00e1ln\u00edmi \u0159e\u0161en\u00edmi","og_url":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/","og_site_name":"EUROTRANSPHARMA","article_published_time":"2025-09-18T07:25:34+00:00","article_modified_time":"2025-09-18T08:03:01+00:00","og_image":[{"width":1851,"height":913,"url":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2025\/09\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg","type":"image\/jpeg"}],"author":"Olha Hlias","twitter_card":"summary_large_image","twitter_misc":{"Napsal(a)":"Olha Hlias","Odhadovan\u00e1 doba \u010dten\u00ed":"5 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#article","isPartOf":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/"},"author":{"name":"Olha Hlias","@id":"https:\/\/www.eurotranspharma.com\/cs\/#\/schema\/person\/c752465ad6b1ea4d80bb1d6cf53f6fea"},"headline":"Distribuce vakc\u00edn v Evrop\u011b: Osv\u011bd\u010den\u00e9 modely pro ka\u017ed\u00fd trh","datePublished":"2025-09-18T07:25:34+00:00","dateModified":"2025-09-18T08:03:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/"},"wordCount":2226,"commentCount":0,"image":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2025\/09\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg","articleSection":["Eurotranspharma","Healthcare transport","Network"],"inLanguage":"cs","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/","url":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/","name":"Distribuce vakc\u00edn v Evrop\u011b | Eurotranspharma","isPartOf":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#primaryimage"},"image":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2025\/09\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg","datePublished":"2025-09-18T07:25:34+00:00","dateModified":"2025-09-18T08:03:01+00:00","author":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/#\/schema\/person\/c752465ad6b1ea4d80bb1d6cf53f6fea"},"description":"Eurotranspharma zaji\u0161\u0165uje GDP distribuci vakc\u00edn v cel\u00e9 Evrop\u011b s kontrolou chladic\u00edho \u0159et\u011bzce v re\u00e1ln\u00e9m \u010dase a lok\u00e1ln\u00edmi \u0159e\u0161en\u00edmi","breadcrumb":{"@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#breadcrumb"},"inLanguage":"cs","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/"]}]},{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#primaryimage","url":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2025\/09\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg","contentUrl":"https:\/\/www.eurotranspharma.com\/wp-content\/uploads\/2025\/09\/Eurotranspharma-Vaccine-distribution-in-Europe.jpg","width":1851,"height":913},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurotranspharma.com\/cs\/distribuce-vakcin-evropa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurotranspharma.com\/cs\/"},{"@type":"ListItem","position":2,"name":"Distribuce vakc\u00edn v Evrop\u011b: Osv\u011bd\u010den\u00e9 modely pro ka\u017ed\u00fd trh"}]},{"@type":"WebSite","@id":"https:\/\/www.eurotranspharma.com\/cs\/#website","url":"https:\/\/www.eurotranspharma.com\/cs\/","name":"EUROTRANSPHARMA","description":"Healthcare Distribution Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurotranspharma.com\/cs\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"cs"},{"@type":"Person","@id":"https:\/\/www.eurotranspharma.com\/cs\/#\/schema\/person\/c752465ad6b1ea4d80bb1d6cf53f6fea","name":"Olha Hlias","image":{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/secure.gravatar.com\/avatar\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a59e21072fe00815e4add52f0bc0757270c3ede25f401156f76ca994614a834?s=96&d=mm&r=g","caption":"Olha Hlias"},"url":"https:\/\/www.eurotranspharma.com\/cs\/author\/295d7e7afdf875edf6f11dba7011e287\/"}]}},"_links":{"self":[{"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/posts\/31812","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/comments?post=31812"}],"version-history":[{"count":2,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/posts\/31812\/revisions"}],"predecessor-version":[{"id":31815,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/posts\/31812\/revisions\/31815"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/media\/31780"}],"wp:attachment":[{"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/media?parent=31812"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/categories?post=31812"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurotranspharma.com\/cs\/wp-json\/wp\/v2\/tags?post=31812"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}